Previous close | 1.4500 |
Open | 1.4500 |
Bid | 1.9800 |
Ask | 2.2900 |
Strike | 12.50 |
Expiry date | 2024-10-18 |
Day's range | 1.4500 - 1.4500 |
Contract range | N/A |
Volume | |
Open interest | 107 |
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Key Insights Institutions' substantial holdings in Novavax implies that they have significant influence over the...